AQST 3.65 (+0.27%)
US03843E1047BiotechnologyBiotechnology

Aquestive Therapeutics (AQST) Stock Highlights

3.65 | +0.27%
2024-12-21 05:27:19
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

Statistics

Range Today
3.52 3.77
Volume Today 1.34M
Range 1 Year
1.84 6.23
Volume 1 Year 429.48M
Range 3 Year
0.62 6.25
Volume 3 Year 683.73M
Range 10 Year
0.62 20.696
Volume 10 Year 1.16B

Highlights

Market Capitalization 497.83M (small)
Floating Shares 80.1M
Current Price 3.65
Price To Earnings -11.33
Price To Revenue 7.76
Earnings Per Share -0.45
Payout Ratio 0%

Performance

Latest +0.27%
1 Month -24.12%
3 Months -29.81%
6 Months +38.26%
1 Year +87.18%
3 Years -37.82%
5 Years -33.15%
10 Years -75.83%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.